1. Crowe RR, Noyes R, Pauls DL, Slymen D. A family study of panic disorder. Arch Gen Psychiatry 1983;40:1065-1069.
2. Torgersen S. Genetics of neurosis. The effects of sampling variation upon the twin concordance ratio. Br J Psychiatry 1983;142:126-132.
3. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568-1578.
4. Yamada K, Nabeshima TJJops. Brain-derived neurotrophic factor/TrkB signaling in memory processes. Am J Pharmacol Sci 2003;91:267-270.
5. Xu MQ, St Clair D, Feng GY, Lin ZG, He G, Li X, et al. BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population. Pharmacogenet Genomics 2008;18:449-457.
7. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer’s disease. J Mol Psychiatry 2001;6:83-86.
8. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-269.
9. Buckley PF. Schizophrenia, An Issue of Psychiatric Clinics-E-Book. Elsevier Health Sciences; 2012.
11. Frustaci A, Pozzi G, Gianfagna F, Manzoli L, Boccia SJN. Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits. Neuropsychobiology 2008;58:163-170.
12. Konishi Y, Tanii H, Otowa T, Sasaki T, Tochigi M, Umekage T, et al. Gene× gene× gender interaction of BDNF and COMT genotypes associated with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014;51:119-125.
13. Konishi Y, Tanii H, Otowa T, Sasaki T, Kaiya H, Okada M, et al. The association of BDNF val66met polymorphism with trait anxiety in panic disorder. J Neuropsychiatry Clin Neurosci 2014;26:344-351.
14. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 2000;157:493-505.
15. Dalby R, Chakravarty M, Ahdidan J, Sørensen L, Frandsen J, Jonsdottir K, et al. Localization of white-matter lesions and effect of vascular risk factors in late-onset major depression. Psychol Med 2010;40:1389-1399.
16. Kim MK, Kim B, Choi TK, Lee SH. White matter correlates of anxiety sensitivity in panic disorder. J Affect Disord 2017;207:148-156.
18. Quigley M, Cordes D, Turski P, Moritz C, Haughton V, Seth R, et al. Role of the corpus callosum in functional connectivity. AJNR Am J Neuroradiol 2003;24:208-212.
19. Walterfang M, Yücel M, Barton S, Reutens DC, Wood AG, Chen J, et al. Corpus callosum size and shape in individuals with current and past depression. J Affect Disord 2009;115:411-420.
24. Taylor WD, Zhao Z, Ashley-Koch A, Payne ME, Steffens DC, Krishnan RR, et al. Fiber tract-specific white matter lesion severity Findings in late-life depression and by AGTR1 A1166C genotype. Hum Brain Mapp 2013;34:295-303.
25. Kim MK, Lee JH, Kim M, Kim W, Moon E, Seo HJ, et al. Korean guidelines for the treatment of panic disorder 2018: initial and maintenance treatment strategies for the pharmacological treatment of panic disorder. Anxiety Mood 2018;14:53-62.
26. Bandelow B, Baldwin DS. Pharmacotherapy for Panic Disorder. In: Simon NM, Hollander E, Barbara O, Rothbaum BO, Stein DJ, editor. The American Psychiatric Association Publishing Textbook of Anxiety, Trauma, and OCD-Related Disorders. Thrid Edition. Washington DC: American Psychiatric Pub, 2020, p. 385-407.
27. Costa P, McCrae R. NEO Five-Factor Inventory (NEO-FFI). Odessa, FL: Psychological Assessment Resources; 1989, p. 3
28. Lim YJ, Yu BH, Kim JH. Korean panic disorder severity scale: construct validity by confirmatory factor analysis. Depress Anxiety 2007;24:95-102.
29. Taylor S, Cox BJ. An expanded anxiety sensitivity index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord 1998;12:463-483.
30. Costa PT, McCrae RR. Normal personality assessment in clinical practice: The NEO Personality Inventory. Psychol Assess 1992;4:5-13.
31. Shear MK, Maser JD. Standardized assessment for panic disorder research: a conference report. Arch Gen Psychiatry 1994;51:346-354.
32. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-II. San Antonio, TX: Psychological Corp; 1996.
34. Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000;283:2529-2536.
35. Roy-Byrne PP, Russo J, Cowley DS, Katon WJ. Unemployment and emergency room visits predict poor treatment outcome in primary care panic disorder. J Clin Psychiatry 2003;64:383-389.
36. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry 1997;154:1571-1575.
39. Sen S, Nesse RM, Stoltenberg SF, Li S, Gleiberman L, Chakravarti A, et al. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacol 2003;28:397-401.
40. Hünnerkopf R, Strobel A, Gutknecht L, Brocke B, Lesch KP. Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacol 2007;32:2552-2560.
41. Hadwin JA, Garner M, Perez-Olivas G. The development of information processing biases in childhood anxiety: a review and exploration of its origins in parenting. Clin Psychol Rev 2006;26:876-894.
42. Mandelli L, Petrelli C, Serretti A. The role of specific early trauma in adult depression: a meta-analysis of published literature. Childhood trauma and adult depression. Eur Psychiatry 2015;30:665-680.
43. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487-1505.
45. Bach M, Laun FB, Leemans A, Tax CM, Biessels GJ, Stieltjes B, et al. Methodological considerations on tract-based spatial statistics (TBSS). NeuroImage 2014;100:358-369.
47. Hofer S, Frahm J. Topography of the human corpus callosum revisited—comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage 2006;32:989-994.
51. Carballedo A, Amico F, Ugwu I, Fagan A, Fahey C, Morris D, et al. Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brainderived neurotrophic factor genotype. Am J Med Genet B Neuropsychiatr Genet 2012;159:537-548.
52. Tost H, Alam T, Geramita M, Rebsch C, Kolachana B, Dickinson D, et al. Effects of the BDNF val 66 met polymorphism on white matter microstructure in healthy adults. Neuropsychopharmacol 2013;38:525-532.
53. Kim B, Shin WS, Kim MK, Lee SH. White matter microstructural changes are associated with alcohol use in patients with panic disorder. J Affect Disord 2016;199:65-72.
54. Han DH, Renshaw PF, Dager SR, Chung A, Hwang J, Daniels MA, et al. Altered cingulate white matter connectivity in panic disorder patients. J Psychiatr Res 2008;42:399-407.